Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [11365]

Immunotherapy and targeted therapy provide new options for difficult-to-treat head and neck cancer

Immunotherapy and targeted therapy provide new options for difficult-to-treat head and neck cancer

How tumours hijack body’s wound healing process

How tumours hijack body’s wound healing process

Largest ever ovarian cancer trial suggests that screening reduces mortality, but longer follow-up is needed

Largest ever ovarian cancer trial suggests that screening reduces mortality, but longer follow-up is needed

SABCS 2015: T-DM1 improved overall survival for heavily pretreated patients with HERr2-positive breast cancer

SABCS 2015: T-DM1 improved overall survival for heavily pretreated patients with HERr2-positive breast cancer

SABCS 2015: No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

SABCS 2015: No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

SABCS 2015: DCIS patients receiving anastrozole reported symptoms different from those receiving tamoxifen both groups reported similar quality of life

SABCS 2015: DCIS patients receiving anastrozole reported symptoms different from those receiving tamoxifen both...

SABCS 2015: Breast-conserving therapy yielded better outcomes than mastectomy for early-stage patients

SABCS 2015: Breast-conserving therapy yielded better outcomes than mastectomy for early-stage patients

SABCS 2015: Mastectomy plus reconstruction has higher complication rates and costs than lumpectomy plus radiation

SABCS 2015: Mastectomy plus reconstruction has higher complication rates and costs than lumpectomy plus radiation

SABCS 2015: Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B

SABCS 2015: Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B

SABCS 2015: Analysis of blood samples finds ESR1 gene mutations are prevalent and associated with worse overall survival

SABCS 2015: Analysis of blood samples finds ESR1 gene mutations are prevalent and associated with worse overall...

More from ecancer